OPA1_Plasma_proteomics.xlsx (252.14 kB)View fileThis item contains files with download restrictions
Next page
Previous page
1/1
Switch ViewSwitch between different file views
Thumbnail viewList viewFile view
2 filesFullscreen
The inhibition of inner mitochondrial fusion in hepatocytes reduces NAFL and improves metabolic profile during obesity by modulating bile acid conjugation.
Version 2 2023-09-01, 13:17Version 2 2023-09-01, 13:17
Version 1 2022-12-12, 15:08Version 1 2022-12-12, 15:08
dataset
posted on 2023-09-01, 13:17authored byLorenzo Da Dalt, Annalisa Moregola, Monika SveclaMonika Svecla, Silvia Pedretti, Francesca Fantini, Mirko Ronzio, Patrizia Uboldi, Diletta Dolfini, Elena Donetti, Andrea Baragetti, Nico Mitro, Luca Scorrano, Giuseppe Danilo NorataGiuseppe Danilo Norata
Mitochondria are constantly undergoing biogenesis, fusion, fission, and mitophagy, ensuring a constant balance between all forms. We investigated the effect of a selective deficiency of OPA1, a protein involved in the fusion of the inner mitochondria membrane, on metabolic lipid disorders in the liver. RNAseq and proteomic analysis revealed that this was due to a change in the mitochondrial-peroxisome-ER axis in hepatocytes, which resulted in hepatic retention of unconjugated bile acids.
Funding
The work was supported by: Telethon Foundation [GGP19146], Progetti di Rilevante Interesse Nazionale [PRIN 2017 K55HLC], Ricerca Finalizzata, Italian Ministry of Health [RF-2019-12370896], PNRR NextGenerationEU [M4C2-Investimento 1.4-CN00000041 National Center for Gene Therapy and Drugs based on RNA Technology] and PNRR NextGenerationEU [Multilayered Urban Sustainability Action – MUSA] to GDN; Ricerca Corrente and 5x1000, Italian Ministry of Health funds to NM